213 related articles for article (PubMed ID: 8989994)
1. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
[TBL] [Abstract][Full Text] [Related]
2. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium.
Scaria A; St George JA; Jiang C; Kaplan JM; Wadsworth SC; Gregory RJ
J Virol; 1998 Sep; 72(9):7302-9. PubMed ID: 9696826
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.
Scaria A; Sullivan JA; St George JA; Kaplan JM; Lukason MJ; Morris JE; Plog M; Nicolette C; Gregory RJ; Wadsworth SC
Mol Ther; 2000 Nov; 2(5):505-14. PubMed ID: 11082324
[TBL] [Abstract][Full Text] [Related]
5. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
Lee MG; Abina MA; Haddada H; Perricaudet M
Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
[TBL] [Abstract][Full Text] [Related]
6. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
7. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
Song W; Kong HL; Traktman P; Crystal RG
Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
[TBL] [Abstract][Full Text] [Related]
9. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.
Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M
Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
Cmielewski P; Donnelley M; Parsons DW
J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
[TBL] [Abstract][Full Text] [Related]
13. Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung.
Kaplan JM; Smith AE
Hum Gene Ther; 1997 Jun; 8(9):1095-104. PubMed ID: 9189767
[TBL] [Abstract][Full Text] [Related]
14. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.
Chirmule N; Moffett J; Dhagat P; Tazelaar J; Wilson JM
Hum Gene Ther; 1999 Nov; 10(17):2839-46. PubMed ID: 10584929
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential.
Kaplan JM; Pennington SE; St George JA; Woodworth LA; Fasbender A; Marshall J; Cheng SH; Wadsworth SC; Gregory RJ; Smith AE
Hum Gene Ther; 1998 Jul; 9(10):1469-79. PubMed ID: 9681418
[TBL] [Abstract][Full Text] [Related]
18. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.
Worgall S; Wolff G; Falck-Pedersen E; Crystal RG
Hum Gene Ther; 1997 Jan; 8(1):37-44. PubMed ID: 8989993
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3.
Lusky M; Grave L; Dieterlé A; Dreyer D; Christ M; Ziller C; Furstenberger P; Kintz J; Hadji DA; Pavirani A; Mehtali M
J Virol; 1999 Oct; 73(10):8308-19. PubMed ID: 10482581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]